140 related articles for article (PubMed ID: 4038825)
21. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
Wickham R
Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
[TBL] [Abstract][Full Text] [Related]
22. Protracted cisplatin-induced vomiting responding to mosapride.
Ganesan P; Sharma A; Mohanti BK; Gogia A
Indian J Cancer; 2010; 47(1):73-4. PubMed ID: 20071797
[No Abstract] [Full Text] [Related]
23. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3639-42. PubMed ID: 2817913
[No Abstract] [Full Text] [Related]
24. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
[TBL] [Abstract][Full Text] [Related]
25. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
26. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
Tanimura S; Banba J; Tomoyasu H; Masaki M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
[TBL] [Abstract][Full Text] [Related]
27. [Anti-emetic treatment for patients with lung cancer after chemotherapy, and usefulness of prochlorperazine for psychiatric emesis].
Inoue S; Endo K; Suzuki H; Endo K
Gan To Kagaku Ryoho; 2000 Mar; 27(3):405-11. PubMed ID: 10740634
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
Tsavaris N; Kosmas CH; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos CH
J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826
[TBL] [Abstract][Full Text] [Related]
29. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
30. Antiemetics for patients treated with antitumor chemotherapy.
Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
[TBL] [Abstract][Full Text] [Related]
31. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
33. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
[TBL] [Abstract][Full Text] [Related]
34. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of ondansetron in patients receiving cisplatin therapy.
Parr MD; McIntyre WJ; Henderson LM; MacDonald JS; Chandler MH
Clin Pharm; 1992 Dec; 11(12):1026-9. PubMed ID: 1286552
[No Abstract] [Full Text] [Related]
36. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
Bishop JF; Olver IN; Wolf MM; Matthews JP; Long M; Bingham J; Hillcoat BL; Cooper IA
J Clin Oncol; 1984 Jun; 2(6):691-5. PubMed ID: 6374058
[TBL] [Abstract][Full Text] [Related]
37. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B
Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789
[TBL] [Abstract][Full Text] [Related]
38. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
39. [Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
Kawashima T; Wada T; Morita N; Ohmata T; Miyata K; Sakamoto T
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2043-8. PubMed ID: 8215479
[TBL] [Abstract][Full Text] [Related]
40. Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
Markman M; Newman DR; Hawkins RS
Cancer Treat Rep; 1985 Mar; 69(3):341-2. PubMed ID: 4038919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
